Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
about
Clinical significance of HIV-1 coreceptor usage.Understanding the HIV coreceptor switch from a dynamical perspective.Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse modelAdoption of an "open" envelope conformation facilitating CD4 binding and structural remodeling precedes coreceptor switch in R5 SHIV-infected macaques.In vivo emergence of HIV-1 highly sensitive to neutralizing antibodiesRelaxation of adaptive evolution during the HIV-1 infection owing to reduction of CD4+ T cell countsMacrophages and Cell-Cell Spread of HIV-1.Coreceptor switch in R5-tropic simian/human immunodeficiency virus-infected macaquesHost factors influencing susceptibility to HIV infection and AIDS progression.Differential evolution of a CXCR4-using HIV-1 strain in CCR5wt/wt and CCR5∆32/∆32 hosts revealed by longitudinal deep sequencing and phylogenetic reconstruction.A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assaysIdentification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques.Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.R5X4 viruses are evolutionary, functional, and antigenic intermediates in the pathway of a simian-human immunodeficiency virus coreceptor switchDendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in transHumoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4.Evolution of HIV-1 coreceptor usage and coreceptor switching during pregnancy.Driving HIV-1 into a Vulnerable Corner by Taking Advantage of Viral Adaptation and Evolution.Coreceptor use in nonhuman primate models of HIV infection.Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.SDF-1/CXCL12 production by mature dendritic cells inhibits the propagation of X4-tropic HIV-1 isolates at the dendritic cell-T-cell infectious synapse.Fitness disadvantage of transitional intermediates contributes to dynamic change in the infecting-virus population during coreceptor switch in R5 simian/human immunodeficiency virus-infected macaques.
P2860
Q27691426-084C1C3E-EE1F-4683-9F40-B2FE437AD076Q30931832-2086C309-778A-4678-823F-94AD1AC6887CQ33638001-E564EF16-7668-46A6-89BD-56A8A4AF50B4Q33676640-9C4B927D-8371-47E3-92D8-98AE77ED4D61Q33961448-5ADA1705-7FF4-4660-A180-7F33A48733C7Q34009730-DB298BC3-7703-44F1-9AD7-42774FD1AF3AQ34328264-0DA81BB2-64A7-4211-B777-A37401A51012Q34931267-08774685-5475-4E07-AC03-09E5263DE804Q35947758-EFBA5EE0-7F27-4972-AF1B-F7BE966A494EQ35995936-7BB88DDC-6CAA-4962-9C8F-E2303D67D30FQ36343848-564B2674-9F80-4065-A2A2-9CBB76C428F5Q36363866-870902C2-0AFD-4954-8C37-7311318403E9Q36484034-0A636D01-342D-4A94-BB3D-6CCDACFF1042Q36608554-B012CFD5-2DCA-4FF3-8436-7CB0628C8CFFQ36699711-C099F9B0-0859-41C1-AD66-B601A49A2A02Q36747765-BD322928-89E9-48D0-B39D-95AEEA3302AEQ36845632-7DDE7B16-9015-4379-8965-069A674F1A6DQ37034798-1A4791E1-9D61-43B8-83C8-CC65547FDB00Q37356010-EDBA73BA-81C2-4EC4-98EF-8093640B29F7Q37610660-B2066FCD-537C-4D74-992D-F549C3999AEBQ37703084-417C1214-D434-42F3-8F64-6253656C8530Q37834099-8B167B21-0427-40E9-AFC3-B4C699F799F8Q38196457-ADAA0BD5-3A24-4DA6-849B-31C38B318096Q39027913-68BD9FAE-1444-4FAC-BD3F-9B75F43519CFQ41230660-EE4D030E-3250-4C5D-A169-3437C2D674EB
P2860
Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Increased neutralization sensi ...... ariants from the same patient.
@ast
Increased neutralization sensi ...... ariants from the same patient.
@en
type
label
Increased neutralization sensi ...... ariants from the same patient.
@ast
Increased neutralization sensi ...... ariants from the same patient.
@en
prefLabel
Increased neutralization sensi ...... ariants from the same patient.
@ast
Increased neutralization sensi ...... ariants from the same patient.
@en
P2093
P2860
P356
P1433
P1476
Increased neutralization sensi ...... variants from the same patient
@en
P2093
Ad C van Nuenen
Brigitte Boeser-Nunnink
Esther D Quakkelaar
Hanneke Schuitemaker
P2860
P304
P356
10.1128/JVI.01983-06
P407
P577
2006-11-01T00:00:00Z